The short explanation
Not necessarily. Women who have been treated for CIN 2 or higher have a slightly raised risk of cervical changes for many years afterwards. India's national programme screens women aged 30 to 65, but some international guidelines (for example in the US) suggest continuing screening for about 25 years after treatment for CIN 2 or higher, even if that goes beyond 65. Your gynaecologist can say which approach suits you. Your normal results since treatment are reassuring, and your risk is now low. Continuing screening is a precaution rather than a sign of concern.
What depends on your situation
The parts of this that change from woman to woman. Uncertainty is stated, not hidden.
- After menopause, an HPV test is often preferred over VIA because it does not depend on seeing the cervix. If the test is uncomfortable because of dryness, a clinician can use a smaller speculum or suggest treating the dryness first.
- Guidelines vary between countries, so it is worth discussing with your gynaecologist, bringing your treatment report and recent results.
What this answer cannot determine
The boundary of online education. These need a clinician who can see you.
- This answer cannot set your schedule. Your gynaecologist can decide based on your full history.
Questions for your clinician
Take these with you. You can add any of them to an appointment card.
- How much longer should I continue screening?
- Is an HPV test suitable for me now?
- Can a smaller speculum be used?
- Which symptoms should I watch for?
When to seek help
Clinician-approved guidance for this topic. When in doubt, being seen is never the wrong choice.
Book an appointment soon
- See a clinician within a few days if you have any vaginal bleeding or a blood-stained discharge.
Raise it at a routine appointment
- Bring your old treatment report to your next screening visit.
Sources
The evidence this explanation is built on.
- Cervical cancer screening National Cancer Institute
- Cervical screening results NHS
- Colposcopy NHS
Who wrote and reviewed this
Every AskHer answer names its author. A clinically reviewed answer also names the clinician who signed it off — if no clinician is named below, it has not been clinically reviewed.
- Author
- AskHer Editorial (AI-assisted) AskHer's editorial team — not an individual clinician Works in English, தமிழ், हिन्दी
- Clinical reviewer
- Nobody yet No clinician has signed this answer off. That is what the “Editorially reviewed” badge means, and why it does not say “Clinically reviewed”. It was written and checked by AskHer’s editorial team against the sources listed above, and it is queued for a clinician who works in this area.
- Review status
- Editorially reviewed
- Last reviewed
- Last reviewed 11 November 2026
- Version
- 1
Correction history
Substantive changes are listed, not quietly edited away.
No corrections have been made since this answer was first published.
Did this answer your question?
Whatever you choose is filed against this version of the answer, never against you, and it is never shown as a count.
“Explain more simply” asks which part was hard to follow, so the author knows what to rewrite. “My question is different” tells the editorial team this answer missed your point, then lets you ask your own question privately. Nothing about you is sent with either.
Saving, following up and reporting are all private. Nothing you do on this page is visible to other readers or to the doctor who wrote it, unless you ask a question.

